These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21692668)

  • 21. [Community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infections].
    Tattevin P
    Med Mal Infect; 2011 Apr; 41(4):167-75. PubMed ID: 21215538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metallo-beta-lactamases as emerging resistance determinants in Gram-negative pathogens: open issues.
    Cornaglia G; Akova M; Amicosante G; Cantón R; Cauda R; Docquier JD; Edelstein M; Frère JM; Fuzi M; Galleni M; Giamarellou H; Gniadkowski M; Koncan R; Libisch B; Luzzaro F; Miriagou V; Navarro F; Nordmann P; Pagani L; Peixe L; Poirel L; Souli M; Tacconelli E; Vatopoulos A; Rossolini GM;
    Int J Antimicrob Agents; 2007 Apr; 29(4):380-8. PubMed ID: 17223319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The rise of resistant gram-negative bacteria].
    Kuijper EJ; van Dissel JT
    Ned Tijdschr Geneeskd; 2010; 154(45):A2868. PubMed ID: 21118590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methicillin-resistant Staphylococcus aureus: a community health threat.
    Cataldo MA; Taglietti F; Petrosillo N
    Postgrad Med; 2010 Nov; 122(6):16-23. PubMed ID: 21084777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology of the resistance of Staphylococcus aureus to antimicrobials].
    Cercenado Mansilla E
    Rev Esp Quimioter; 2006 Mar; 19(1):83-4. PubMed ID: 16688297
    [No Abstract]   [Full Text] [Related]  

  • 26. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. First international spread and dissemination of the virulent Queensland community-associated methicillin-resistant Staphylococcus aureus strain.
    Ellington MJ; Ganner M; Warner M; Boakes E; Cookson BD; Hill RL; Kearns AM
    Clin Microbiol Infect; 2010 Jul; 16(7):1009-12. PubMed ID: 19624515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative activity of daptomycin against clinical isolates of methicillin-resistant Staphylococcus aureus and coagulase-negative staphylococci].
    Picazo JJ; Betriu C; Rodríguez-Avial I; Culebras E; López F; Gómez M;
    Enferm Infecc Microbiol Clin; 2010 Jan; 28(1):13-6. PubMed ID: 19406529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antimicrobial susceptibility of Staphylococcus aureus and characterization of methicillin-resistant Staphylococcus aureus isolated from bovine mastitis in Korea.
    Nam HM; Lee AL; Jung SC; Kim MN; Jang GC; Wee SH; Lim SK
    Foodborne Pathog Dis; 2011 Feb; 8(2):231-8. PubMed ID: 21034263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
    Streit JM; Jones RN; Sader HS; Fritsche TR
    Int J Antimicrob Agents; 2004 Aug; 24(2):111-8. PubMed ID: 15288308
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial resistance: Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA - its evolving antimicrobial resistance and implications for therapy.
    Chua K; Laurent F; Coombs G; Grayson ML; Howden BP
    Clin Infect Dis; 2011 Jan; 52(1):99-114. PubMed ID: 21148528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ceftaroline activity against pathogens associated with complicated skin and skin structure infections: results from an international surveillance study.
    Jones RN; Mendes RE; Sader HS
    J Antimicrob Chemother; 2010 Nov; 65 Suppl 4():iv17-31. PubMed ID: 21115451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial activity of secondary metabolite from marine isolate, Pseudomonas sp. against Gram positive and negative bacteria including MRSA.
    Charyulu EM; Sekaran G; Rajakumar GS; Gnanamani A
    Indian J Exp Biol; 2009 Dec; 47(12):964-8. PubMed ID: 20329699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An overview of antimicrobial susceptibility patterns for gram-negative bacteria from the National Antimicrobial Resistance Surveillance Thailand (NARST) program from 2000 to 2005.
    Apisarnthanarak A; Buppunharun W; Tiengrim S; Sawanpanyalert P; Aswapokee N
    J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S91-4. PubMed ID: 21298849
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial activity and spectrum of daptomycin: results from the surveillance program in Australia and New Zealand (2008).
    Bell JM; Turnidge JD; Sader HS; Jones RN
    Pathology; 2010; 42(5):470-3. PubMed ID: 20632825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular characterization of resistance to mupirocin in methicillin-resistant Staphylococcus aureus isolates in a tertiary hospital in Spain.
    Daskalaki M; Otero JR; Chaves F
    J Antimicrob Chemother; 2009 Apr; 63(4):826-8. PubMed ID: 19223301
    [No Abstract]   [Full Text] [Related]  

  • 37. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline.
    Reinert RR; Low DE; Rossi F; Zhang X; Wattal C; Dowzicky MJ
    J Antimicrob Chemother; 2007 Nov; 60(5):1018-29. PubMed ID: 17855724
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacodynamic profiling of intravenous antibiotics against prevalent Gram-negative organisms across the globe: the PASSPORT Program-Asia-Pacific Region.
    Roberts JA; Kwa A; Montakantikul P; Gomersall C; Kuti JL; Nicolau DP
    Int J Antimicrob Agents; 2011 Mar; 37(3):225-9. PubMed ID: 21168997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
    Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
    Fritsche TR; Sader HS; Stilwell MG; Dowzicky MJ; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):195-201. PubMed ID: 16105564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.